1. Home
  2. CASH vs OGN Comparison

CASH vs OGN Comparison

Compare CASH & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pathward Financial Inc.

CASH

Pathward Financial Inc.

HOLD

Current Price

$82.52

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.39

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CASH
OGN
Founded
1954
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
CASH
OGN
Price
$82.52
$13.39
Analyst Decision
Buy
Hold
Analyst Count
2
5
Target Price
$107.50
$11.40
AVG Volume (30 Days)
181.3K
2.6M
Earning Date
04-22-2026
05-07-2026
Dividend Yield
0.23%
0.60%
EPS Growth
18.88
N/A
EPS
4.89
0.55
Revenue
$839,894,000.00
$6,216,000,000.00
Revenue This Year
$7.56
$0.45
Revenue Next Year
$6.02
$1.67
P/E Ratio
$16.78
$24.42
Revenue Growth
11.29
N/A
52 Week Low
$65.93
$5.69
52 Week High
$101.26
$13.49

Technical Indicators

Market Signals
Indicator
CASH
OGN
Relative Strength Index (RSI) 49.91 68.61
Support Level $81.14 $10.05
Resistance Level $84.62 $13.46
Average True Range (ATR) 2.28 0.05
MACD 0.44 -0.11
Stochastic Oscillator 59.40 23.08

Price Performance

Historical Comparison
CASH
OGN

About CASH Pathward Financial Inc.

Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: